### 29754 Federal Register / Vol. 78, No. 98 / Tuesday, May 21, 2013 / Notices

**SUMMARY :**  In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) meeting on ‘‘Estimating the Costs of Supporting Primary Care Practice Transformation (R03)’’.

**DATES :**  July 11–12, 2013 (Open on July 11 from 8:00 a.m. to 8:30 a.m. and closed for the remainder of the meeting).

**ADDRESSES :**  Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda,
MD 20814.

**FOR FURTHER INFORMATION CONTACT :**  Anyone wishing to obtain a roster ofmembers, agenda or minutes of the nonconfidential portions of this meeting should contact: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone: (301) 427–

1554.

Agenda items for this meeting are subject to change as priorities dictate.

**SUPPLEMENTARY INFORMATION :**  A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members ofthe Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for ‘‘AHRQ RESEARCH SERVICE AWARDS (NRSA) INSTITUTIONAL RESEARCH TRAINING GRANTS (T32) Special Emphasis Award’’ are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: May 8, 2013. Carolyn M. Clancy, AHRQ Director.
[FR Doc. 2013–11578 Filed 5–20–13; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Notice of Meetings**

**AGENCY :**  Agency for Healthcare Research and Quality (AHRQ), HHS.

**ACTION :**  Notice of Five AHRQ Subcommittee Meetings.

**SUMMARY :**  The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. These meetings will be closed to the public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C. section 552b(c)(4), and 5 U.S.C. section 552b(c)(6).

**DATES :**  See below for dates of meetings:

1. Healthcare Safety and Quality Improvement Research (HSQR)

Date: June 19–20, 2013 (Open from 8:00 a.m. to 8:30 a.m. on June 19 and closed for remainder of the meeting)

2. Healthcare Effectiveness and Outcomes Research (HEOR)

Date: June 19–20, 2013 (Open from 8:00 a.m. to 8:30 a.m. on June 19 and closed for remainder of the meeting)

3. Healthcare Information Technology Research (HITR)

Date: June 19–21, 2013 (Open from 8:00 a.m. to 8:30 a.m. on June 19 and closed for remainder of the meeting)

4. Health Care Research and Training (HCRT)

Date: June 20, 2013 (Open from 8:00 a.m. to 8:30 a.m. on June 20 and closed for remainder of the meeting)

5. Health System and Value Research (HSVR)

Date: July 09–10, 2013 (Open from 8:00 a.m. to 8:30 a.m. on July 09 and closed for remainder of the meeting)

**ADDRESSES :**  The five meetings will take place at the following locations:
HSQR, HEOR, HITR, HCRT

Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, Maryland 20878.

HSVR

Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD 20814.

**FOR FURTHER INFORMATION CONTACT :**  (To obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.)

Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427–
1554.

**SUPPLEMENTARY INFORMATION :**  In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the scientific peer review groups listed above, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committee. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Agenda items for these meetings are subject to change as priorities dictate.

Dated: May 8, 2013. Carolyn M. Clancy, AHRQ Director.
[FR Doc. 2013–11576 Filed 5–20–13; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Board of Scientific Counselors, National Center for Injury Prevention**  **and Control, (BSC, NCIPC)**

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:

Times and Dates: 8:30 a.m.–7:00 p.m., June 13, 2013 (Open). 8:30 a.m.–2:00 p.m., June 14, 2013 (Closed).

Place: CDC, Century Center, 1825 Century Boulevard NE., Room 1042–1B, Atlanta, Georgia 30345

Status: Portions of the meeting as designated above will be closed to the public in accordance with the provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463.